CFO appointment
KULR Technology Group, Inc. appoints Michael Philip Kimel as CFO
KULR Technology Group, Inc. reported in a Form 8-K filed June 9, 2026 that Michael Philip Kimel was appointed Chief Financial Officer, effective June 9, 2026.
In the filing's words
Effective June 9, 2026, the Company appointed Dr. Kimel as Chief Financial Officer of the Company. Dr. Kimel has served as a member of the Company’s Board of Directors and, most recently, as Chair of its Audit Committee.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | KULR Technology Group, Inc. (KULR) |
|---|---|
| Event | Appointment |
| Incoming | Michael Philip Kimel |
| Title in the filing | Chief Financial Officer |
| Effective | June 9, 2026 |
| 8-K filed | June 9, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Chair of its Audit Committee, KULR Technology Group, Inc. |
| SEC CIK | 0001662684 |
KULR Technology Group, Inc. reported this change in a Form 8-K, Item 5.02, filed June 9, 2026. The filing's own words are quoted above.
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Michael Philip Kimel? Send a correction with the primary source.